Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
B io Factsheet www.curriculum-press.co.uk Number 268 The Biology of skin cancer Each year there are 45,000 new cases of skin cancer diagnosed in the UK – 123 a day! 6000 of these are malignant melanomas, which kill 1600 people annually. The incidence of malignant melanoma is increasing rapidly and the main reason is sunbathing. This Factsheet: • Describes the causes and characteristics of malignant melanomas • Describes the most common type of exam questions on this topic • Outlines the most common errors and misconception that Chief Examiners have reported in students’ exam scripts A malignant melanoma is a type of cancer – a mass of cells that divide continuously and in an uncontrolled way. Malignant means that the cancer can spread to other parts of the body (Fig 1). Fig. 1 Types of skin cancer Hair follicle Horny layer Squamous cells: Cancers take the form of scaly lumps, ulcers, nodules or sores that will not heal Epidermis Melanocytes: Produce the protective pigment melanin but can develop malignant melanomas (MM) which, if undetected, can rapidly spread around the body. Moles can also develop into MM Melanocytes Sebaceous glands Basal cells: The most common skin cancer – basal cell carcinoma develops here Dermis Sweat glands Free nerve endings Lymphatic channels Blood vessels Nerve fibres Subcutaneous layer Pacinian corpuscles 1 Bio Factsheet 268 The Biology of skin cancer www.curriculum-press.co.uk Malignant melanoma is the most dangerous type of skin cancer and its incidence is increasing rapidly (Fig.2). Cancer is uncontrolled mitosis Fig.2 Malignant melanoma The rate of cell division is controlled by two types of genes: 1. proto-oncogenes which stimulate cell division 2. tumour suppressor genes that slow cell division A mutation in a proto-oncogene results in an oncogene that then stimulates cells to divide too quickly. 14 cases of malignant melanomas 12 A mutation in a tumour suppressor gene can cause it to become inactivated and the rate of cell division again becomes uncontrolled. 10 rate per 100 000 population 8 The resulting mass of unspecialized, non-functioning cells is known as a tumour. death from malignant melanomas 6 Typical Exam Question 4 (a) How do benign tumours differ from malignant tumours? (2) (b) Describe two ways in which tumours may damage the body (2) (c) Outline the link between excessive exposure to the sun and skin cancer (3) (d) (i) Fair - skinned people are at a greater risk of skin cancer than dark - skinned people when sunbathing. Explain why (1) (ii) Early humans with dark skins evolved in tropical Africa and slowly spread out across the world. Natural selection then resulted in a range of skin pigmentation in different populations. Suggest the advantage of pale skin in humans living in Northern Europe (1). 2 0 1970 1980 1990 Year 2000 2010 Mortality has not increased as fast as incidence because of better diagnosis, better public awareness with more careful self-checking and better treatment. Ultraviolet radiation Both UV-A and UV-B (Fig.3) in sunlight can cause DNA mutations that result in skin cancer. (a) benign tumours do not cause cancer; benign tumours do not invade other tissues causing damage; if parts of benign tumours break off and spread they do not result in new tumours/metastasis; (b) may directly damage or exert pressure on organs/blood vessels; may cause blockages/obstructions; (c) solar radiation contains UV radiation; UV causes mutation of genes which control division; ref to proto-oncogenes; ref to tumour suppression genes; (d) (i) fair skin has less melanin which protects against UV Reject “ no melanin” (ii) less blocking of UV needed to synthesise vitamin D; Fig.3 The electromagnetic spectrum gamma rays x-rays infrared UV microwaves radio waves UVA UVB visible light Violet 380 Indigo 440 Blue 480 Green Yellow Orange 540 600 640 red 680 720 Fig.4 summarises one sequence of events that results in malignant skin cancer. Markscheme Fig. 4 The development of malignant skin cancer Extract from Chief Examiner’s Report Candidates struggled to explain how tumours actually damage the body. Some believed that metastasis involved whole tumours traveling around the body. Many believed that tumours cause blood clots. Only the most able candidates made any reference to proto-oncogenes or tumour suppression genes. Common misconceptions were that UV radiation interacts with melanin to cause skin cancer and that dark-skinned people had a darker pigment than fair-skinned people, rather than just more melanin. UV radiation damages DNA È Mutation in the genes responsible for cell division and growth È Abnormal, uncontrolled pattern of cell division and growth to form a tumour (undifferentiated mass of cells) È Tumour may damage surrounding cells or damage or block blood vessels È Cancerous cells break off and cancer spreads via blood or lymph to other body organs (metastasis) Hint: This is a very common exam problem 2 Bio Factsheet 268 The Biology of skin cancer www.curriculum-press.co.uk Exam Hints 1. Don’t call it ultraviolent radiation 2. Don’t write “ Cancer is rapid cell division”. Instead write “ Cancer is uncontrolled cell division” 3. Learn to spell melanin 4. Don’t confuse melanin with melanoma 5. It isn’t true that fair-skinned people have no melanin 6. Cancer cells can’t be passed on from one generation to another! Treating skin cancer Table 1 summarises the main ways of treating skin cancer. Table.1 Treating skin cancer Technique Procedure Surgery Cancerous cells are cut out along with some healthy surrounding tissue Cryotherapy Small areas of cancerous cells e.g. basal cell carcinomas are frozen with liquid nitrogen. A blister and then scab forms and after two weeks the scab falls off and the cancer cells should have been killed Radiotherapy Often used for basal and squamous cell carcinomas and following surgery to make sure all the cancerous cells are dealt with. Video of radiotherapy at Royal Marsden Hospital: http://www.macmillan.org.uk/ Cancerinformation/Cancertreatment/Treatmenttypes/Radiotherapy/Radiotherapy.aspx Photodynamic therapy Uses light and a light-sensitive drug to kill cancerous cells Topical chemotherapy Used for early squamous cell and superficial basal cell carcinomas Topical immunotherapy Used for some basal cell and squamous cell carcinomas Typical Exam Question (a) Some anti-cancer drugs work by attacking tumours. What is a tumour? (1) (b) Melanoma is a particularly aggressive form of skin cancer and in the past few patients survive for more than five years. However, the Human Genome Project has proved extremely useful in helping develop new drugs that, in clinical trials, are showing great promise. Suggest how work on the Human Genome Project has helped in the development of more effective drugs (2) (a) mass of cells dividing uncontrollably; (b) Human Genome Project has identified genes/alleles/mutations linked to cancers/melanomas; New drug effectively targets these genes/alleles; ref to mechanism e.g. prevents gene expression/translation; Markscheme How Science Works: Sun Protection Factors Suncreams help to block UV radiation from the Sun. The effectiveness of different creams is rated on a scale referred to as the Sun Protection Factor (SPF) based on how long it takes skin to develop sunburn relative to unprotected skin. Scientists investigating different suncreams have shown that the SPF scale is unreliable because: • • • • manufacturers failed to consistently test levels of sunburn the ease of sunburn depends on a person’s skin type manufacturers used different UV frequencies in their tests it measures protection against sunburn not protection against skin cancer Question: Why do you think the manufacturers chose protection against sunburn rather than protection against the risk of developing skin cancer as the basis of the SPF scale? Hopefully, you identified factors such as: • Studying sunburn is a lot faster than studying skin cancer • Many other factors influence cancer • A large sample would be needed to study cancer, thus it would be more expensive • Monitoring sunburn is easier than monitoring skin cancer 3 Bio Factsheet 268 The Biology of skin cancer www.curriculum-press.co.uk Practice Questions Markschemes 1. Scientists investigated a new form of chemotherapy for treating skin cancer. The graph shows the effect of different doses of the chemotherapy drug on both tumour cells and on healthy body cells. 1. (a) UV damages DNA in skin cells/ causes mutation; Uncontrolled cell division/cell division exceeds cell death; Disruption of tumour suppressor genes / oncogenes; Tumour is undifferentiated mass of cells; Damages tissues/blood vessels/healthy cells; A B Percentage of cells killed C (b) A kills a proportion of cancer cells but a low proportion of healthy cells; But many cancer cells are not killed; So multiple treatments required; B kills a high proportion of cancer cells but a low proportion of healthy cells; so would cause fewer side effects; C kills all tumour cells; but too many healthy cells; Healthy cells Tumour cells (c) (i) drug affects allele expression; mutation/mutated protein not produced; drug kills melanoma cells rapidly; melanoma cells don’t divide/ are replaced with normal body cells; via mitosis/ named process in mitosis; Dose of drug (a) Describe the sequence of events leading to the formation of a skin cancer tumour (3). (b) Outline the relative advantages and disadvantages of doses A, B and C (4). (ii) randomised trial; double blind/ neither doctors not patients know who is getting the drug or a placebo; uses large number of patients; quantitative/statistical analysis of effectiveness of the drug; (c) Scientists conducted clinical trials of a new drug aimed at treating malignant melanomas. The drug appears to achieve a 45% shrinkage of melanomas in just 12 weeks. (i) Suggest how the new drug may have caused the melanoma to shrink in only 12 weeks (3). (ii) The drug is now entering a phase III trial, before it can be approved for use. Explain what happens in a phase III trial (2) 2. (a) malignant – capable of spreading and causing harm; melanoma – cancer/cells undergoing uncontrolled division; (b) melanomas take time to develop/exposure when young but cancer triggered later; early effects sub-lethal; metastasis affects vital organs after many years; immune system becomes less effective as people age; cumulative exposure to UV over the years; 2. The graph shows the death rate from malignant melanomas in fair-skinned men in different age groups. 20 Death rate 15 per 100,000 of the population 10 5 0 20 30 35 40 45 50 55 60 65 70 75 80 Age at death/years (a) Explain the term malignant melanoma (2) (b) Suggest three reasons for the trend shown in the graph (3) Acknowledgements: This Factsheet was researched and written by Kevin Byrne.. Curriculum Press, Bank House, 105 King Street, Wellington, Shropshire, TF1 1NU. Bio Factsheets may be copied free of charge by teaching staff or students, provided that their school is a registered subscriber. No part of these Factsheets may be reproduced, stored in a retrieval system, or transmitted, in any other form or by any other means, without the prior permission of the publisher. ISSN 1351-5136 4